See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 4, 2006

Menopause Hypertension (High Blood Pressure) Cold Sores (Herpes Labialis Infections)

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:


This research study is testing an investigational medication to relieve the intensity and frequency of menopause symptoms. Volunteers 45-65 naturally menopausal for at least six months OR surgically menopausal for at least six weeks who are experiencing seven or more moderate-to-severe hot flashes per day may be eligible. Participants may be compensated for time and travel.

The research site is in Chaska, Minn.

More information

Please see


Hypertension (High Blood Pressure)

This is a research study of an investigational combination of medications for high blood pressure. Candidates at least 18 diagnosed with high blood pressure but not severe high blood pressure may qualify. Participants will be provided all study related exams, study medication, and compensation of up to $315 for time and travel.

The research site is in Longmont, Colo.

More information

Please see


Cold Sores (Herpes Labialis Infections)

This is a research study of an investigational drug for children with cold sores (herpes simplex infection). The investigational drug is already FDA-approved to treat herpes simplex in adults. Volunteers between ages 1 and 12 with a history or current diagnosis of cold sores or herpes simples infection may qualify. The patient cannot have any condition that could affect drug absorption or metabolism.

The research sites are located across the United States.

More information

Please see


Copyright 2006 CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.